Schroder Investment Management Group
MDGL icon

Schroder Investment Management Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Schroder Investment Management Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2M Buy
51,630
+11,778
+30% +$6.03M 0.02% 497
2026
Q1 		$20.1M Buy
39,852
+10,801
+37% +$5.16M 0.02% 533
2025
Q4 		$17M Buy
29,051
+12,439
+75% +$6.35M 0.01% 546
2025
Q3 		$7.36M Sell
16,612
-16,595
-50% -$6.19M 0.01% 712
2025
Q2 		$10M Buy
33,207
+2,801
+9% +$835K 0.01% 636
2025
Q1 		$9.97M Buy
30,406
+19,359
+175% +$6.36M 0.01% 642
2024
Q4 		$3.44M Sell
11,047
-9,795
-47% -$2.75M ﹤0.01% 843
2024
Q3 		$4.43M Buy
20,842
+8,134
+64% +$2.08M ﹤0.01% 804
2024
Q2 		$3.56M Sell
12,708
-10,993
-46% -$2.62M ﹤0.01% 840
2024
Q1 		$6.33M Buy
23,701
+5,401
+30% +$1.27M 0.01% 739
2023
Q4 		$4.23M Buy
+18,300
New +$3.2M 0.01% 798
2020
Q1 		– Sell
-981
Closed -$89K – 1358
2019
Q4 		$89K Buy
+981
New +$95.1K ﹤0.01% 1212

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Schroder Investment Management Group's MDGL Position: Q2 2026 in Review

Schroder Investment Management Group increased its Madrigal Pharmaceuticals (MDGL) stake by 30% in Q2 2026, buying an estimated $6.03M and bringing the position to 51,630 shares worth $27.2M. The position accounts for 0.02% of the portfolio, ranked #497.

Schroder Investment Management Group first reported a position in MDGL in Q4 2019 and has held it in 12 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Schroder Investment Management Group held 51,630 shares of Madrigal Pharmaceuticals worth $27.2M as of Q2 2026.
  • Schroder Investment Management Group bought 11,778 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $6.03M.
  • Madrigal Pharmaceuticals made up 0.02% of Schroder Investment Management Group's portfolio in Q2 2026, its #497 holding.
  • Schroder Investment Management Group first reported a position in Madrigal Pharmaceuticals in Q4 2019 and has held it in 12 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.